The hugely increasing numbers of diabetics is a medical and financial burden worldwide. Diabetics can, for example, suffer eye and kidney problems and more - five percent of them develop vascular diseases, leading to lower limb and feet ulcerations, which frequently result in amputations if not treated in time. Percutaneous transluminal angioplasty (PTA) can heal ulcers and, because it is…
A study published by the Journal of the American Medical Association (JAMA) recently has found that those with type 2 diabetes who had a diet high in low-glycemic foods such as nuts, beans and lentils had greater improvement in glycemic control and risk factors for coronary heart disease than those on a diet with an emphasis on high-cereal fibre.
Das Center for Cardiovaskular Research (CCR) an der Berliner Charité konnte sich durch vielseitige Grundlagenforschung über die deutschen Landesgrenzen hinaus bereits einen Namen machen. Nun stellt das CCR in einem aktuellen Zwischen- bericht unter anderem vielversprechende Ent- wicklungen einer neuen Medikamentenklasse bei Endorganschäden und die Erforschung der Blutgefäßbildung bei…
In a strategic move intended to enhance the global launch of its 'groundbreaking' diabetes monitoring device, set to help combat the 'worldwide epidemic', the US company Sensys Medical has chosen to relocate its world headquarters to the United Kingdom (UK).
The 2nd international symposium `Diabetic foot: surgery, therapy, rehabilitation´ took place on the beginning of October in St. Petersburg. Olga Ostrovskaya reports from Russia
A panel of experts, convened by the American Diabetes Association and the European Association for the Study of Diabetes, has issued updated treatment recommendations for type 2 diabetes, in a consensus statement published online in two journals: Diabetes Care and Diabetologia*.
There's little evidence that newer, more expensive drugs work any better than older, cheaper medications. Diabetes, which came 7th in the list of the USA's top mortality causes in 2006, has hit a new high.
When from 19 to 22 November the world's largest medical fair takes place in Dusseldorf, the entire city is in a kind of emergency state: hotels are bustin' out of their seams, traffic periodically comes to a standstill and at night exhibitors and visitors alike crowd the narrow streets of the Altstadt and the fancy hotel bars and enjoy whatever entertainment North Rhine-Westphalia's capital has…
Diabetes presents a special challenge for the young. Here we see how a young Swiss girl has successfully come to terms with her metabolic disorder. A true life story from Bayer HealthCare Diabetes Care (BayNews)
Die erste am Universitätsklinikum Carl Gustav Carus vorgenommene Transplantation von Inselzellen aus einer Bauchspeicheldrüse verlief erfolgreich: Zwei Wochen nach dem Eingriff bildet die seit 51 Jahren an Diabetes Typ 1 erkrankte Patientin wieder körpereigenes Insulin. Die Transplantation ist Ergebnis einer über zwei Jahre dauernden, aufwendigen Aufbauarbeit an Uniklinikum und Medizinischer…
The next flu season will come. To prevent high-risk people from infections, the National Institute for Health and Clinical Excellence (NICE) recently published a final guidance on the use of the drugs oseltamivir, amantadine and zanamivir for the prophylaxis of influenza. "But vaccination is the main way to prevent flu", says Gillian Leng, NICE Deputy Chief Executive.
At the opening of the Johnson & Johnson Diabetes Institute in Paris experts took the opportunity to warn against the growing incidence of diabetes. They reinforced the believe that improved education measures as a key enabler for patients to better manage the condition. They predicted that in 2025 the number of people with diabetes wil have increased by 20 percent in Europe.
Good news for diabetes patients in the UK: According to a report published recently by the Department of Health, diabetes care in the NHS is improving and focusing more on prevention. The result: More patients have been identified, and in more people at risk development of the condition could be prevented.
Yes, it is, according to a prospective cohort study published in CMAJ. The study was conducted by researchers from the Hong Kong Institute of Diabetes and Obesity, the Li Ka Shing Institute of Health Science and The Chinese University of Hong Kong. Their result: A V-shaped risk relation between LDL cholesterol and cancer in patients not receiving statin therapy.
People with diabetes are often interested to be involved in research trials, according to the patient organization UK Diabetes. Therefore, the Diabetes Research Network (DRN) announced an initiative which shall help diabetics to play a greater role in research.
Researchers have discovered a potential new treatment for diabetes by isolating and killing defective cells which prevent the natural production of insulin. The investigation opens the door to a potential therapy for patients with type 1 diabetes.
New research claims that nearly four million people in the UK may be unaware they are at high risk of heart disease. An University of Oxford team screened more than 71,000 people aged over 18 across England, Wales and Scotland.
Researchers at Linköping University and Uppsala University in Sweden can show that accumulation of protein aggregatess, amyloid, in the transplanted cells may be causing their death. With the aid of their results, physicians can enhance survival of islets transplants and improve treatment of type 1 diabetes.
ESC speaker John Cleland from the University of Hull, UK, sumed up the latest treatment available for patients with diabetes mellitus and expressed his worries about side-effects and efficacy of available anti-diabetic drugs. If you want to read his ESC abstract, just click the “read more” button.
Bayer HealthCare Diabetes Care unveiled the new CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.
The German Federal Ministry of Education and Research recently agreed funding for a diabetes competence network — the first diabetes mellitus project to be funded by the ministry's new “Health Research — Research for People” programme.
According to a study conducted by researchers at the University of Zurich and the Zurich University Hospital the answer is: Yes. They demonstrated that one injection per month sufficed to improve blood sugar levels significantly. Even more: The insulin production of the patients improved.
Transition Therapeutics Inc. announced that the first patient has been dosed in a Phase 2 clinical study of gastrin analogue, TT-223, in patients with type 2 diabetes. Gastrin based therapies are an emerging class of potential disease-modifying treatments for patients with diabetes.
Approximately 31 million people in the European Union are suffering from diabetes, a devastating disease with severe consequences for patients and their families, but also for the society at large and the economic prosperity of Europe. This week EH Online will focus on innovative strategies in diabetes care and on new management systems to support physicians and patients alike. Moreover, we will…
Optimal treatment of diabetes is very difficult to achieve since many obstacles have to be overcome such as expensive treatments, poor patient compliance or insufficient datac. With these challenges in mind, a new research project titled "Computerassisted Diabetes Risk Management (CDRM)" was put in place to examine how eHealth solutions can improve diabetes care.